Search results

Results 1 – 20 of 1,608
Advanced search

Search in namespaces:

There is a page named "BioMarin" on Wikipedia

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide...
    19 KB (1,671 words) - 02:47, 24 June 2024
  • Thumbnail for Tetrahydrobiopterin
    typical cost of treating a patient with Kuvan is US$100,000 per year. BioMarin holds the patent for Kuvan until at least 2024, but Par Pharmaceutical...
    32 KB (2,819 words) - 20:05, 10 May 2024
  • gene therapy used for the treatment of hemophilia A. It was developed by BioMarin Pharmaceutical. Valoctocogene roxaparvovec is made of a virus (AAV5) that...
    17 KB (1,233 words) - 06:25, 18 December 2023
  • Approves BioMarin's Voxzogo (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close" (Press release). BioMarin Pharmaceutical...
    19 KB (1,337 words) - 02:27, 16 July 2024
  • Thumbnail for Mucopolysaccharidosis
    Naglazyme), a recombinant enzyme replacement therapy also produced by Biomarin was approved for MPS VI (Marateaux-Lamy syndrome). In July 2006, the United...
    27 KB (3,047 words) - 23:21, 13 August 2024
  • is a synthetic version of this enzyme. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug...
    6 KB (522 words) - 15:11, 8 March 2024
  • Rare-Disease Portfolio". BioMarin. November 24, 2014. Archived from the original on March 22, 2015. "FDA Accepts BioMarin's NDA for Drisapersen". Parent...
    7 KB (634 words) - 03:04, 12 July 2024
  • mandated to follow GMP, and they, as well as BioMarin, are subject to inspection and review. BioMarin's facility has received both FDA and European Commission...
    17 KB (1,575 words) - 06:47, 14 August 2024
  • Thumbnail for Amifampridine
    salt form, which was developed through a series of companies ending with BioMarin Pharmaceutical which obtained European approval in 2009 under the trade...
    33 KB (3,193 words) - 22:16, 5 August 2024
  • Thumbnail for Nasdaq-100
    from the index on July 24 due to its acqusition by AT&T, and replaced by BioMarin Pharmaceutical on July 27. Sigma-Aldrich was removed on July 31, after...
    59 KB (5,060 words) - 00:01, 26 July 2024
  • Thumbnail for Phenylketonuria
    2020-08-05. "BioMarin : Pipeline : Pipeline Overview : BMN 165 for PKU". bmrn.com. Archived from the original on 2015-01-01. "BioMarin Provides Updates...
    58 KB (6,180 words) - 21:50, 31 July 2024
  • Thumbnail for Marin County, California
    MarinHealth (1,100) Fireman's Fund Insurance Company (950) Autodesk (878) BioMarin Pharmaceutical (871) Safeway Inc. (841) Comcast (620) Macy's (380) Bradley...
    91 KB (5,552 words) - 07:03, 8 August 2024
  • phosphate to treat LEMS for the North American market from BioMarin. In 2012, while BioMarin had a Phase III trial ongoing in the US, it licensed the US...
    16 KB (1,470 words) - 08:17, 9 May 2024
  • and GSK2402968) is an experimental drug that was under development by BioMarin, after acquisition of Prosensa, for the treatment of Duchenne muscular...
    8 KB (746 words) - 01:31, 11 June 2024
  • Thumbnail for Talazoparib
    (ctDNA)-based next generation sequencing assays. Talazoparib was developed by BioMarin Pharmaceutical Inc. and Medivation Inc. acquired all worldwide rights to...
    16 KB (1,214 words) - 05:39, 12 April 2024
  • Thumbnail for Merck Group
    October 2015, Merck revealed it would return the rights of the Kuvan drug to BioMarin Pharmaceutical Inc. The drug is effective in the treatment of the rare...
    47 KB (4,708 words) - 08:20, 3 August 2024
  • Thumbnail for PARP inhibitor
    PMID 32411727. BioMarin Pharmaceutical Inc. (28 July 2011). "BioMarin Announces Second Quarter 2011 Financial Results". prnewswire.com. "BioMarin Initiates...
    20 KB (2,065 words) - 16:33, 5 July 2024
  • Thumbnail for Novato, California
    Research on Aging, and several biotech firms, such as Biosearch Technologies, BioMarin Pharmaceutical and Ultragenyx. Several small technology companies are also...
    42 KB (3,949 words) - 16:31, 9 June 2024
  • produced in 2000, followed by testing in animal models until 2014. In 2012, BioMarin began the first clinical trial on affected patients using their recombinant...
    19 KB (1,800 words) - 07:30, 15 July 2024
  • (1978– ) BioCryst (1986– ) Bioderma (1977– ) Bio Farma (1890– ) Biogen (1978– ) Bioinvent (1983– ) BioLineRx (2003– ) BioMarin (1997– ) bioMérieux (1963–...
    34 KB (2,168 words) - 01:30, 4 August 2024
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)